Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PIH1 domain-containing protein 1 (PIH1D1) is a molecular scaffold and substrate recognition subunit of the R2TP complex, an HSP90 co-chaperone system required for the assembly and stabilization of multiple large macromolecular machines, such as small nucleolar ribonucleoproteins (snoRNPs), RNA polymerase II, and the mTORC1 and SMG1 kinase complexes[2][3][4]. PIH1D1 contains a phosphopeptide-binding PIH-N domain that specifically recognizes phosphorylated motifs, recruiting phosphorylated client proteins (e.g., TEL2, ECD) in a highly sequence-specific and phosphorylation-dependent manner[2][3]. Through this substrate recognition, PIH1D1 orchestrates proper assembly and stability of multisubunit factors involved in transcription, ribosome biogenesis, and cell signaling, with key localizations in the cytoplasm and nucleolus[1][4]. Defects or mutations can lead to diseases involving ribonucleoprotein assembly or ciliary function, such as primary ciliary dyskinesia[4]. There are currently no direct inhibitors, drugs, or biomarkers in clinical use for PIH1D1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PIH1 domain-containing protein 1 (PIH1D1).